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Abstract
Background: The use of mapping algorithms have been suggested as a solution to predict health utilities when no
preference-based measure is included in the study. However, validity and predictive performance of these algorithms are
highly variable and hence assessing the accuracy and validity of algorithms before use them in a new setting is of importance.
The aim of the current study was to assess the predictive accuracy of three mapping algorithms to estimate the EQ-5D-3L from
the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) among Swedish people with knee disorders.
Two of these algorithms developed using ordinary least squares (OLS) models and one developed using mixture model.
Methods: The data from 1078 subjects mean (SD) age 69.4 (7.2) years with frequent knee pain and/or knee osteoarthritis from
the Malmö Osteoarthritis study in Sweden were used. The algorithms’ performance was assessed using mean error, mean
absolute error, and root mean squared error. Two types of prediction were estimated for mixture model: weighted average
(WA), and conditional on estimated component (CEC).
Results: The overall mean was overpredicted by an OLS model and underpredicted by two other algorithms (P < 0.001).
All predictions but the CEC predictions of mixture model had a narrower range than the observed scores (22 to 90 %).
All algorithms suffered from overprediction for severe health states and underprediction for mild health states with lesser
extent for mixture model. While the mixture model outperformed OLS models at the extremes of the EQ-5D-3D
distribution, it underperformed around the center of the distribution.
Conclusions: While algorithm based on mixture model reflected the distribution of EQ-5D-3L data more accurately
compared with OLS models, all algorithms suffered from systematic bias. This calls for caution in applying these
mapping algorithms in a new setting particularly in samples with milder knee problems than original sample. Assessing
the impact of the choice of these algorithms on cost-effectiveness studies through sensitivity analysis is recommended.
Keywords: Mapping algorithms, WOMAC, EQ-5D-3L, Knee pain, Knee osteoarthritis, External validity
Background
Quality-adjusted life years (QALYs) is a very common out-
come measure applied in cost-utility analysis. QALY
combines both health-related quality of life (HRQoL) and
survival into a single metric, where survival is weighted by
health utilities. These health utilities are cardinal values
ranging from 1 (equivalent to full health) to zero (equiva-
lent to death) with possible negative values for health
states worse than death [1]. The health utilities can be
elicited using direct method (e.g., standard gamble,
time trade-off ) or indirect method applying a generic
preference-based measure of HRQoL. The EuroQol five-
dimension (EQ-5D) is a widely used generic preference-
based measure of HRQoL to elicit health utilities.
However, many clinical studies continue to use condition-
specific measures of HRQoL that are non-preference-
based and have limited use in estimating health utilities
and in cost-utility analyses. In response to this, the use
of mapping algorithms have been suggested as a solution
to predict health utilities from these condition-specific
non-preference-based measures when no preference-based
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measure is included in the study [2, 3]. However, validity
and predictive performance of these algorithms are highly
variable [2] and concerns on their reliability and accuracy
had been raised [4]. It has been shown that different
algorithms can result in different incremental cost-
effectiveness ratios and possibly discrepant funding
decisions [5]. These concerns imply that assessing the
accuracy and validity of algorithms before use them in
a new setting is of importance. This assessment is
known as external validity and determine to what
extent the results of a mapping algorithm can be general-
ized/applied to other people/setting. It should be noted
that in assessing external validity of any prediction model,
one should distinguish between model reproducibility and
model transportability [6]. The former refers to model
performance in a new sample with similar case mix as the
original sample, while the latter refers to model perform-
ance in a new sample with different case mix compared
with the original sample [6].
In the study of knee pain and knee osteoarthritis (OA),
the Western Ontario and McMaster Universities Osteoarth-
ritis Index (WOMAC) is a commonly used as disease-
specific non-preference-based measure [7]. To enable using
the WOMAC in cost-utility analysis, three algorithms have
been developed to estimate EQ-5D-3L from the WOMAC
[8–10] and had been used in cost-utility analyses [11, 12].
To our best knowledge, no previous study compared the
predictive accuracy of these algorithms in an external sam-
ple of people with knee pain and OA. To fill this knowledge
gap, the aim of the current study was to compare the
predictive accuracy of these algorithms in a large sample of
Swedish patients with knee pain and/or knee OA who
answered to both EQ-5D-3L and WOMAC questionnaires.
In the current study, we investigated whether EQ-5D-3L
can be reliably predicted from WOMAC using current
algorithms. This is an important question since presence of
any difference between actual and predicted values can have
crucial impact on cost-utility analyses and funding decisions.
Methods
Data
We used the data from the Malmö OA (MOA) study
originating from the Malmö Diet and Cancer Study. In the
first stage of the MOA study, a postal questionnaire about
knee pain was sent to a random sample of 10 000 subjects
from the Malmö Diet and Cancer Study who were still alive
and resident in the Malmö area in 2007. Respondents were
asked about whether they have had knee pain during the
previous 12 months and its duration (<1 week, 1–4 weeks,
1–3 months, >3 months). Subjects with pain in one or both
knees in the past 12 months and duration of minimum
1 month were classified as having knee pain. In the second
stage of the MOA, a random sample of 1 300 subjects with
knee pain and 650 subjects without knee pain were invited
to a clinical visit and radiographic examination [13]. A total
of 1 527 subjects participated in the second stage and
responded to the EuroQol-5D-3L (EQ-5D-3L) and the
Knee injury and Osteoarthritis Outcome Score (KOOS)
questionnaires. For this study we used the data on 494
subjects with knee pain without knee OA and 584 sub-
jects with knee OA (either clinical [14] or/and radio-
graphic [15, 16]). The subjects with neither knee pain nor
knee OA (n = 419) were not included as the algorithms
were not intended to be applied for these people. An
addition of 40 subjects were excluded due to missing on
knee OA status (n = 30), EQ-5D-3L (n = 8), and WOMAC
(n = 2) questionnaires (Fig. 1).
HRQoL measures
The EQ-5D-3L is a generic preferences-based health
measure covering five attributes: mobility, self-care, usual
activities, pain/discomfort, and anxiety/depression. Each
attribute has three levels: no problems, some or moderate
problems, and severe problems, resulting in 243 (35) pos-
sible health states [17]. The responses to these attributes
were weighted using the UK [18] time trade-off value set
to calculate observed UK EQ-5D-3L index scores.
The WOMAC is a disease-specific questionnaire consist-
ing of three domains: “pain”, “stiffness”, and “physical func-
tion” [7]. Since the KOOS was developed based on the
WOMAC LK 3.0 questionnaire, the WOMAC subscale
scores can be calculated from the KOOS. Using responses
to questions P5-P9 (5 questions) from KOOS-pain subscale,
S6-S7 (2 questions) from KOOS- other symptoms subscale,
and A1-A17 (17 questions) KOOS-ADL subscale, we calcu-
lated scores for pain, stiffness and physical functions sub-
scales of the WOMAC, respectively. The response options
for these questions are none (0), mild (1), moderate (2),
severe (3) or extreme (4). This means that scores range
0–20 for pain subscale, 0–8 for stiffness subscale, 0–68 for
physical function subscale, and 0–96 for total WOMAC
score (higher scores indicate more problems).
Algorithms
Three algorithm are currently available to estimate the
EQ-5D-3L index scores from the WOMAC. The algorithm
developed by Barton et al. [8] used data on 348 individuals
with knee pain in the UK. The mean UK EQ-5D-3L index
score was 0.557 and the mean WOMAC subscales were as
follow: 7.76 for pain, 3.91 for stiffness, and 27.89 for physical
function. In this algorithm, the UK EQ-5D-3L index scores
were modelled by ordinary least squares (OLS) regression
(EQ-5D-3L index score =−0.3474012785− 0.0005977709*
WOMAC total score − 0.0001081560*WOMAC total
score2 + 0.0326027536*age− 0.0002352456*age2 + 0.04758896
87*sex) [8]. The algorithm developed by Xie et al. [9] included
a sample of 258 subjects with knee OA in Singapore. In this
study the Japanese value set [19] was used to calculate
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the EQ-5D-3L index scores. The mean Japanese EQ-5D-3L
index score was 0.62 with following scores on the
WOMAC subscales: 6.64 on pain, 3.12 on stiffness, and
26.24 on physical function. The final model was developed
using the OLS model (EQ-5D-3L index score = 0.83414 −
0.00166*WOMAC pain score − 0.00092*WOMAC stiffness
score − 0.00330*WOMAC function score). The algorithm
developed by Wailoo et al. [10] used 7 072 observations
from 1 768 subjects with knee or hip OA from three hospi-
tals in Spain. These subjects had a mean UK EQ-5D-3L
index score of 0.29 with scores of 11.37, 4.70, and 43.85 on
the WOMAC pain, stiffness, and physical function, re-
spectively. In this algorithm, a random effects adjusted
limited dependent variable mixture model based on a
distribution specific to the characteristics of EQ-5D was
applied. This model was used to account for the
characteristics of EQ-5D-3L data including the right and
left bounding, a mass of observations at 1.0 (full health), a
large gap between full health and the next feasible EQ-
5D-3L value, and multimodality of the distribution [20].
The final algorithm had a mixture of five components and
these components and probability of their membership
were estimated using WOMAC pain, WOMAC stiffness,
WOMAC function, their quadratic terms, age, and sex
[10]. We used the EQ-5D calculator provided by Wailoo
et al. [10] to estimate EQ-5D-3L index scores from the
WOMAC (the calculator is available at: http://hqlo.
biomedcentral.com/articles/10.1186/1477-7525-12-37).
Statistical analysis
The algorithms were applied to the WOMAC responses
and the EQ-5D-3L index scores were predicted (in follow,
Fig. 1 Flow diagram of the study design
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we identified each algorithm by the name of the first
author). It should be noted that two types of predictions
can be estimated from mixture models [21]: 1) “weighted
average (WA)” as the sum of predictions for each compo-
nent multiplied by probability of component membership,
and 2) “conditional on estimated component (CEC)”
which is equal to the prediction for the component with
the maximum membership probability. We calculated
both these values for the Wailoo algorithm [10].
The predictive accuracy was assessed by evaluating the
scatter plots of the observed scores versus prediction error,
and calculation of the mean error, the mean absolute error
(MAE), the root mean squared error (RMSE), and the pro-
portion of absolute errors greater than 5 %, 10 %, and 25 %
of observed scores. The MAE is the mean of absolute dif-
ferences between the observed and predicted EQ-5D-3L
index scores, whilst the RMSE is defined as the squared
root of the mean of squared differences between the
observed and predicted EQ-5D-3L index scores. These are
recommended and widely used measures in assessing the
performance of mapping algorithms [2] and smaller values
of MAE/RMSE show better model performance. In
addition, the performance of the algorithms according to
severity of health states (ranked by EQ-5D-3L index score)
and knee problems (ranked by total WOMAC score) were
assessed. All analyses were performed in Microsoft Excel
and STATA 13 (StataCorp LP, College Station, TX, USA).
Results
The mean (SD) age and body mass index of the subjects
included in the study were 69.4 (7.2) years and 28.2
(5.0), respectively, and 66.3 % were women (Table 1). Of
these subjects, 45.8 % had knee pain without knee OA,
6.3 % had knee OA without knee pain, and 47.9 % had
knee OA with knee pain. The mean (SD) scores on
WOMAC-pain, stiffness, and physical function were 5.92
(4.05), 2.63 (1.91), and 21.86 (14.70), respectively. The
mean (SD) EQ-5D-3L index score was 0.718 (0.214). A
total of 48 out of 243 possible EQ-5D-3L health states were
observed in the study sample and four health states 11121,
21121, 11111, and 11122 constitute 68.2 % of the observed
EQ-5D-3L health states (Additional file 1: Table S1).
The Barton OLS model and Wailoo mixture model (both
WA and CEC predictions) underpredicted the overall
mean observed score while the Xie OLS model overpre-
dicted it (mean errors were lower for the Xie and Wailoo
CEC than two other predictions). While the range of pre-
dicted scores were narrower than the observed scores for
Barton (88 %), Xie (21.9 %), and the WA prediction from
Wailoo (90 %), the CEC prediction from Wailoo had a
wider range (109 %). Surprisingly, none of the OLS-based
models were capable of predicting any value above 0.83
and the minimum value predicted by the Xie OLS model
was 0.58 (Table 2). Two OLS-based models underesti-
mated the observed variance but the mixture model over-
estimated it (the WA prediction from mixture model had
very similar variance to the observed one). The distribution
of observed and predicted scores showed that predictions
from mixture model particularly the CEC predictions
more accurately capture the observed distribution com-
pared with the OLS models (Fig. 2). The Spearman rank
correlation coefficients between the observed scores and
predicted scores were moderate for both individual and
EQ-5D-3L health states (Additional file 1: Table S2).
While examining prediction errors across EQ-5D-3L
health states revealed that all algorithms suffered from
overprediction for severe health states and underpredic-
tion for mild health states, this systematic bias declined
to some extend in the CEC prediction of mixture model
(Fig. 3 and Additional file 2: Figure S1A). Assessing the
predictive accuracy of the algorithms by levels of EQ-5D-
3L index scores showed that mixture models (particularly
the CEC predictions) outperformed the OLS models at
Table 1 Characteristics of the study sample
Subjects with frequent
knee pain and no
knee OA (n = 489)
Subject with knee OA
(with or without frequent
knee pain) (n = 579)
Women, % 70.8 62.5
Age, years (SD) 68.2 (7.2) 70.4 (7.0)









WOMAC scores, mean (SD)
Pain 4.7 (3.6) 7.0 (4.1)
Stiffness 2.0 (1.7) 3.2 (1.9)
Physical function 17.3 (13.5) 25.8 (14.5)
Table 2 Summary statistics of the observed and predicted
EQ-5D-3L index scores
Mean SD Median Min Max
Observed 0.718 0.214 0.727 −0.181 1.0
Barton prediction 0.642 0.157 0.682 −0.207 0.829
Xie prediction 0.750 0.056 0.750 0.576 0.834
Wailoo prediction_WA 0.648 0.219 0.662 −0.096 0.972
Wailoo prediction_CEC 0.676 0.280 0.703 −0.290 0.995
SD standard deviation, WA weighted average, CEC conditional on
estimated component
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the extremes of the EQ-5D-3L distribution and under-
performed around the center of the distribution (Table 3).
Moreover, while there were J-shape relationships between
the MAE/RMSE and severity of EQ-5D-3L health state for
the OLS models, the corresponding relationships were
linear for mixture model (i.e., increase in MAE/RMSE as
health state severity increased).
Assessing the predictive accuracy of the algorithms by
levels of knee problems showed that the Barton OLS
model underpredicted the observed EQ-5D-3L at almost
all range of total WOMAC score (Fig. 4). On the other
hand, the Xie OLS model overpredicted at mild knee
problems (total WOMAC< 10) and overpredicted for
remaining range of total WOMAC score. The mixture
model overpredicted at total WOMAC scores less than
20 and underpredicted for higher levels. The MAE showed
that the OLS models underperformed mixture model at
mild knee problems and outperformed at most severe
knee problems (Table 4). For all algorithms the lowest and
highest MAE/RMSE were observed at total WOMAC
score of 10–30 and 50–100, respectively. In addition, there
were no statistically significant differences between the
mean observed scores and WA (CEC) prediction of mix-
ture model for total WOMAC score of 10–30 (30–50).
Fig. 2 The distribution of the observed and predicted EQ-5D-3L index scores in the study sample
Fig. 3 The prediction error versus the observed EQ-5D-3L index scores
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Table 3 Predictive accuracy of the algorithms by the observed UK EQ-5D-3L index score
EQ-5D-3L
index
n Barton Xie Wailoo
WA CEC
<0.5 100 ME (95 % CI) 0.308 (0.267 to 0.349) 0.551 (0.529 to 0.574) 0.256 (0.209 to 0.303) 0.219 (0.151 to 0.288)
MAE 0.325 0.551 0.281 0.324
RMSE 0.372 0.563 0.350 0.410
0.5–0.699 193 ME (95 % CI) −0.111 (−0.130 to −0.091) 0.057 (0.049 to 0.065) −0.144 (−0.169 to −0.119) −0.126 (−0.165 to −0.086)
MAE 0.142 0.063 0.187 0.194
RMSE 0.177 0.079 0.228 0.307
0.7–0.899 645 ME (95 % CI) −0.098 (−0.106 to −0.089) −0.013 (−0.017 to −0.009) −0.094 (−0.106 to −0.081) −0.054 (−0.070 to −0.038)
MAE 0.110 0.038 0.147 0.139
RMSE 0.147 0.048 0.187 0.211
0.9–1.0 130 ME (95 % CI) −0.215 (−0.223 to −0.206) −0.183 (−0.188 to −0.179) −0.096 (−0.113 to −0.079) −0.062 (−0.081 to −0.042)
MAE 0.215 0.183 0.096 0.062
RMSE 0.221 0.185 0.137 0.131
All 1068 ME (95 % CI) −0.076 (−0.087 to −0.066) 0.032 (0.021 to 0.043) −0.070 (−0.082 to −0.058) −0.042 (−0.057 to −0.028)
MAE 0.148 0.108 0.161 0.157
RMSE 0.194 0.191 0.210 0.249
Absolute error >
|0.05 observed|, %
78.8 58.2 82.8 75.3
Absolute error >
|0.10 observed|, %
64.7 36.4 65.9 53.3
Absolute error >
|0.25 observed|, %
29.7 11.3 36.2 24.3
CI confidence interval, ME mean error, MAE mean absolute error, RMSE root mean square error, WA weighted average, CEC conditional on estimated component
Fig. 4 The observed and predicted mean EQ-5D-3L index scores by total WOMAC score
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Discussion
The external validity of the current algorithms to estimate
EQ-5D-3L from the WOMAC were, for the first time,
evaluated in a truly independent sample of middle aged
and elderly people with knee pain and knee OA. The
result revealed that the algorithms systematically and sta-
tistically significantly overpredicted the observed scores
for severe health states and underpredicted for mild health
states. We also found that mixture model particularly
predictions based on CEC reflect the characteristics of
EQ-5D-3L distribution more accurately compared to
OLS models. Moreover, while mixture model outperformed
the OLS models at the extremes of the EA-5D-3L distribu-
tion, it underperformed at the middle of the distribution.
We found statistically significantly differences between
the overall mean observed and predicted EQ-5D-3L index
scores, even though the magnitude of prediction error
particularly for the Xie OLS model and the CEC predic-
tion of mixture model was low and can be considered
acceptable in an external sample. In addition, as expected,
the MAEs in our external sample was higher than values
reported in the original samples (15 % larger for Barton
[8] and 46 % larger for Xie [9]; no MAE was reported by
Waillo [10]). However, the range of the MAEs observed in
our external validation (0.108–0.161) was similar to values
reported by previous mapping algorithms [2]. In line with
previous studies [20, 21] we found that while the OLS
models outperformed either of predictions of mixture
model in the total sample, the latter performed better
at the extremes of the EQ-5D-3L distribution. It should
be noted that the OLS models performed better in the
total sample mainly because they had better perform-
ance around the center of the observed distribution
where a large proportion of our data were clustered
(71.5 % of the observed EQ-5D-3L values were between
0.65 and 0.80). The tendency of predicted EQ-5D-3L
values from OLS models to regress toward mean might
explain this phenomenon [21] particularly for the Xie
OLS model which developed using the Japanese value
set [19] with a narrower range than the UK value set
[18]. Interestingly, the Xie OLS model with the best
performance in the total sample was not capable of pre-
dicting any EQ-5D-3L value above 0.84 and below 0.57
while 24.3 % of the observed values were distributed in
these ranges. This implies that if we had more observa-
tions outside the range of 0.6 to 0.8, then the mixture
model possibly outperformed the OLS models.
For all algorithms the worst predictive accuracy was
observed in severe health states/knee problems implying
that the predicted values for these health states should
be applied with high caution regardless of the applied algo-
rithm. More importantly, all algorithms suffered from over-
prediction for severe health states and underprediction for
mild health states. These problems have been previously
reported in the literature [2, 4, 22] and the presence of the
N3 term in the UK value set and large decrement in utility
due to this term has been suggested as a potential explan-
ation [23]. Moreover, while mixture model has been ap-
plied to overcome this systematic bias [20, 21], our results
showed that they can diminish it but cannot eliminate it.
This systematic bias can potentially resulted in under-
estimating of health gain particularly for quality of life-
improving interventions. While such underestimation
has been reported by Barton et al. [8], the actual impact
of two other mapping algorithms on health gains and
cost-utility analyses should be investigated in a longitu-
dinal study.
There are several potential explanations for observed
differences between the actual and predicted EQ-5D-3L
index scores. The degree of conceptual overlap between
Table 4 Predictive accuracy of the algorithms by total WOMAC score interval
Total WOMAC n Barton Xie Wailoo
WA CEC
0–10 195 ME (95 % CI) −0.081 (−0.106 to −0.057) −0.053 (−0.078 to −0.029) 0.048 (0.024 to 0.072) 0.093 (0.069 to 0.117)
MAE 0.143 0.132 0.110 0.117
RMSE 0.191 0.181 0.175 0.195
10–30 326 ME (95 % CI) −0.021 (−0.034 to −0.009) 0.013 (0.002 to 0.025) 0.004 (−0.009 to 0.017) 0.019 (0.003 to 0.034)
MAE 0.068 0.057 0.080 0.101
RMSE 0.113 0.109 0.117 0.141
30–50 336 ME (95 % CI) −0.085 (−0.104 to −0.066) 0.034 (0.016 to 0.053) −0.119 (−0.137 to −0.100) −0.014 (−0.033 to 0.005)
MAE 0.160 0.093 0.184 0.112
RMSE 0.195 0.175 0.210 0.178
50–100 211 ME (95 % CI) −0.143 (−0.175 to −0.111) 0.135 (0.100 to 0.170) −0.218 (−0.250 to −0.185) −0.307 (−0.350 to −0.264)
MAE 0.258 0.187 0.295 0.351
RMSE 0.277 0.294 0.322 0.443
CI confidence interval, ME mean error, MAE mean absolute error, RMSE root mean square error, WA weighted average, CEC conditional on estimated component
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a disease-specific measure and EQ-5D-3L plays a cru-
cial role in the strength of the algorithms [2]. As the
WOMAC mainly concentrate on physical problems re-
lated to knee and do not directly capture emotional
problems such as depression and anxiety, the overlap
between the WOMAC and EQ-5D-3L might be limited.
In mapping the Health Assessment Questionnaire (HAQ)
to EQ-5D-3L, Hernández Alava et al. [20] found that add-
ing pain as one of the main domains in the EQ-5D-3L
which is not included in the HAQ summary score im-
proved the models predictive accuracy. Therefore, adding
emotional problems to the mapping algorithms of the
WOMAC to EQ-5D.3L might have similar positive impact
on the model fit of mapping algorithms. In addition,
possible variations in overlap between the WOMAC
and EQ-5D-3L across populations can influence the
predictive accuracy of the mapping algorithms.
The inherent differences in populations (e.g., socio-
cultural, health status, clinical practice patterns, and access
to health care services) between the estimation and valid-
ation samples might partially explain the observed differ-
ences. For example, our study sample had less severe knee
problems compared to the samples used in developing
mapping algorithms. However, it should be highlighted
that transportability of a prediction model entails that a
model performs well across samples with different case
mix compared to the original sample [6]. Moreover, in
practice an available algorithm will be applied in variety
of settings and populations and therefore assessing the
transportability of mapping algorithms is important. The
results of our study suggest that generalizability of the
current mapping algorithms to estimate EQ-5D-3L from
the WOMAC in a sample with mild knee problems is lim-
ited. Furthermore, differences induced by translation, and
applied questionnaires (using the WOMAC directly versus
applying the KOOS in our study) might also partially ex-
plain our findings.
The variation in performance of the mapping algorithms
implies that using different algorithms might produce dif-
ferent QALYs and cost-utility results. Such possibility has
been reported in the literature [5, 8, 24] and need to be
taken into account by policy makers when making
decisions based on findings from these algorithms because
it is possible that pharmaceutical companies select an
algorithm that support cost-effectiveness of their prod-
ucts. In this situations, assessing the impact of the choice
of mapping algorithms on cost-effectiveness results
through sensitivity analysis has been suggested [5, 24].
The current study has several limitations that should be
considered when interpreting its findings. Only 48 (20 %)
of 243 the possible EQ-5D-3L health states were observed
in our study sample. This limits the generalizability of our
findings to other patient population where the other
EQ-5D-3L health states might be more common. In
addition, the higher EQ-5D-3L and WOMAC scores in our
sample implies that we mainly assessed the transportability
of the mapping algorithms and could not assess reproduci-
bility of them. Difference in applied method to compute the
WOMAC scores (indirect calculation of the WOMAC
scores using the KOOS) compared to the method applied
in the mapping studies (direct application of the
WOMAC) might cause differences in participants’ re-
sponses. However, the KOOS questionnaire includes the
WOMAC Osteoarthritis Index LK 3.0 in its complete and
original format and therefore difference might be trivial.
Due to the lack of longitudinal data on changes in health
status, we were not able to assess the impact of the
algorithms on QALY gain and cost-effectiveness studies.
In addition, this avoid possibility of assessing responsive-
ness and test-retest reliability of the algorithms.
Conclusion
The current algorithms to estimate EQ-5D-3L from the
WOMAC suffer from overprediction for severe health
states and underprediction for mild health states which
might lead to underestimation of QALY gain. While the
predictions from mixture model particularly those based
on classification diminish this systematic bias, they were
not able to eliminate it. The mixture model outperformed
the OLS models at the extremes of the EQ-5D-3L distri-
bution and more accurately captured the characteristics
of the distribution. It should be noted that our findings
do not invalidate the current mapping algorithms but
imply that the mapping algorithms might have limited
generalizability to population with milder knee prob-
lems compared with the estimation samples.
Our results highlight the importance of external valid-
ation of the algorithms and supports the recommenda-
tions in the literature to directly collect data on utilities
using preference based instruments and considering map-
ping algorithms as second-best solution [2, 8, 25, 26]. In
addition, due to variation in performance of the mapping
algorithms, we support assessing the impact of the choice
of algorithms on cost-utility analysis through sensitivity
analysis. Investigating the impact of the algorithms on
cost-effectiveness studies, assessing their predictive accur-
acy in a sample with more severe knee problems, and
developing a mapping algorithm for patients with mild
knee problems are topics for future studies.
Additional files
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